Home › JMP Securities Upgrades BioCryst Pharmaceuticals to Outperform
 

Keywords :   


JMP Securities Upgrades BioCryst Pharmaceuticals to Outperform

2013-07-21 14:54:31| Biotech - Topix.net

The firm currently has a $3.00 price objective on the stock. JMP Securities' price target would indicate a potential upside of 21.95% from the stock's previous close.

Tags: securities upgrades pharmaceuticals outperform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »